title: Dietary obacunone supplementation stimulates muscle hypertrophy, and suppresses hyperglycemia and obesity through the TGR5 and PPARγ pathway.
abstract: Obacunone is a limonoid that is predominantly found in Citrus. Although various biological activities of limonoids have been reported, little is known about the beneficial effects of obacunone on metabolic disorders. In the present study, we examined the effects of dietary obacunone supplementation on obese KKAy mice, to clarify the function of obacunone in metabolic regulation. Mice were pair-fed a normal diet either alone or supplemented with 0.1% w/w obacunone for 28 days. Compared with the control, obacunone-fed mice had lower glycosylated hemoglobin, blood glucose, and white adipose tissue weight, although there was no significant difference in body weight. Obacunone treatment also significantly increased the weight of the gastrocnemius and quadriceps muscles. Reporter gene assays revealed that obacunone stimulated the transcriptional activity of the bile acids-specific G protein-coupled receptor, TGR5, in a dose-dependent manner. In addition, obacunone inhibited adipocyte differentiation in 3T3-L1 cells and antagonized ligand-stimulated peroxisome proliferator-activated receptor γ (PPARγ) transcriptional activity. These results suggest that obacunone stimulates muscle hypertrophy and prevents obesity and hyperglycemia, and that these beneficial effects are likely to be mediated through the activation of TGR5 and inhibition of PPARγ transcriptional activity.
authors.affiliation: Research and Development Division, Kikkoman Corporation, Chiba, Japan. Electronic address: thoriba@mail.kikkoman.co.jp.
authors.forename: Taro
authors.initials: T
authors.lastname: Horiba
authors.affiliation: Research and Development Division, Kikkoman Corporation, Chiba, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Katsukawa
authors.affiliation: Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan.
authors.forename: Moeko
authors.initials: M
authors.lastname: Mita
authors.affiliation: Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan.
authors.forename: Ryuichiro
authors.initials: R
authors.lastname: Sato
mesh_terms: D000818:Animals; D001584:Benzoxepins / Q000008:administration & dosage* / Q000494:pharmacology; D019587:Dietary Supplements; D057809:HEK293 Cells; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D006984:Hypertrophy / Q000209:etiology; D036701:Limonins / Q000008:administration & dosage* / Q000494:pharmacology; D024821:Metabolic Syndrome / Q000517:prevention & control; D051379:Mice; D018482:Muscle, Skeletal / Q000187:drug effects*; D009765:Obesity / Q000517:prevention & control*; D047495:PPAR gamma / Q000037:antagonists & inhibitors / Q000378:metabolism*; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000378:metabolism*
chemical_list: D001584:Benzoxepins; C473772:GPBAR1 protein, human; D036701:Limonins; D047495:PPAR gamma; D043562:Receptors, G-Protein-Coupled; C067207:obacunone
keywords: Hyperglycemia; Hypertrophy; Obacunone; Obesity; PPARγ; TGR5